Method and composition for treating irritable bowel syndrome using low doses of opioid receptor antagonists

Details for Australian Patent Application No. 2005202245 (hide)

Owner Albert Einstein College of Medicine of Yeshiva University

Inventors Fleischner, Gerald M.; Shen, Ke-Fei; Crain, Stanley M.

Agent Shelston IP

Pub. Number AU-A-2005202245

Parent 780013

Filing date 24 May 2005

Wipo publication date 16 June 2005

International Classifications

A61K 031/14 - Quaternary ammonium compounds, e.g. edrophonium, choline

Event Publications

9 June 2005 Complete Application Filed

16 June 2005 Application Open to Public Inspection

  Published as AU-A-2005202245

25 October 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005202246-Vascular adhesion molecules and modulation of their function

2005202244-Improved Pullulan Free Edible Film Compositions and Methods of Making the Same